- The first known study of the prevalence of prescription opioid use disorder (pOUD) in a representative, nonclinical population sample in Germany found the 1-year prevalence to be 21.2%.
Why this matters
- Although prescription opioid use is increasing in Europe, research on the rate of pOUD in European countries is limited.
- Cross-sectional secondary data analysis of 9204 participants in the 2015 Epidemiological Survey of Substance Abuse in Germany.
- Funding: None.
- 3.5% (n=275) of participants had received an opioid prescription in the previous year.
- Of those, 21.2% were diagnosed with pOUD, 6.4% of whom had moderate and severe pOUD.
- 15.3% of the pOUD group reported the additional use of illegal opioids in the past year vs 3.8% of those without pOUD.
- Independent risk factors (ORs; 95% CIs) for pOUD included:
- Depression: 2.69 (1.13-6.38).
- Inexplicable physical complaints: 2.68 (1.14-6.31).
- Other psychiatric diagnosis: 4.12 (1.36-12.43).
- Use of nonopioid painkillers was associated with decreased risk for pOUD (OR, 0.27; 95% CI, 0.09-0.81).
- Potential underreporting of addictive behavior.